News Archives

SPR Therapeutics Named a Top Workplace for Second Consecutive Year

June 25, 2023

– Selection based on employee satisfaction and engagement – Cleveland, Ohio – June 25, 2023 – SPR Therapeutics has been selected as a Top Workplaces honoree for the second year in a row by …

Category: News

Real-World Data from Over 6,100 Patients Corroborates Significant Pain Reduction from Prior Prospective Studies for Patients Treated with SPRINT® PNS

May 17, 2023

Cleveland, Ohio – May 17, 2023 – SPR® Therapeutics announced the publication of a comprehensive real-world retrospective data analysis of over 6,100 patients demonstrating significant pain relief …

Category: News

SelectHealth Initiates Peripheral Nerve Stimulation (PNS) Coverage to Support Patient Need for Effective Non-opioid Pain Treatment

May 4, 2023

Cleveland, Ohio – May 4, 2023 – SelectHealth, a non-profit health plan with over one million members, has demonstrated leadership amid the opioid crisis by creating one of the first coverage policies …

Category: News

New SPRINT extensa XT^® System with Bimodal PNS^™ Offers Synergistic Treatment of Pain

April 25, 2023

Cleveland, Ohio – April 25, 2023 – SPR® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, announced …

Category: News

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

SPR Therapeutics Named a Top Workplace for Second Consecutive Year

Real-World Data from Over 6,100 Patients Corroborates Significant Pain Reduction from Prior Prospective Studies for Patients Treated with SPRINT® PNS

SelectHealth Initiates Peripheral Nerve Stimulation (PNS) Coverage to Support Patient Need for Effective Non-opioid Pain Treatment

New SPRINT extensa XT^® System with Bimodal PNS^™ Offers Synergistic Treatment of Pain

SPR® Therapeutics Named #1 on Crain’s Cleveland Business Fast 50 list

SPR® Therapeutics Debuts New SPRINT® PNS Data for Low Back, Shoulder, Knee, and Headache at the 23rd Annual ASRA Pain Medicine Meeting

Ben Austin, CFO and COO of SPR® Therapeutics, Named to Crain’s Cleveland Business 40 Under 40 List

SPR Therapeutics Founder and CEO Maria Bennett on managing pain with nerve stimulation, not drugs: Women Who Lead